Establishment of novel anti-TIM-3 antibodies interfering with its binding to ligands-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Establishment of novel anti-TIM-3 antibodies interfering with its binding to ligands

Published:2024-04 Issue:7 Volume:10 Page:e28126
ISSN:2405-8440
Container-title:Heliyon
language:en
Short-container-title:Heliyon

Author:

Yan Zhuohong^ORCID,Ma Teng^ORCID,Wang Xiaojue,Yi Ling,Wei Panjian,Zhang Hongtao,Wang Jinghui

Funder

Beijing Municipal Administration of Hospitals

Publisher

Elsevier BV

Reference45 articles.

1. Co-Inhibition of TIGIT and PD-1/PD-L1 in cancer immunotherapy: mechanisms and clinical trials;Chu;Mol. Cancer,2023

2. Genetic characteristics involving the PD-1/PD-L1/L2 and CD73/A2aR axes and the immunosuppressive microenvironment in DLBCL;Zhang;J Immunother Cancer,2022

3. The dual role of CD70 in B-cell lymphomagenesis;Nie;Clin. Transl. Med.,2022

4. OX40 shapes an inflamed tumor immune microenvironment and predicts response to immunochemotherapy in diffuse large B-cell lymphoma;Lu;Clin. Immunol.,2023

5. TIM3 comes of age as an inhibitory receptor;Wolf;Nat. Rev. Immunol.,2020

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monoclonal Antibody Therapies in Cancer Immunotherapy;Advances in Medical Diagnosis, Treatment, and Care;2024-08-28

2. Immune Checkpoint Inhibitors in Cancer Immunotherapy;Advances in Medical Diagnosis, Treatment, and Care;2024-08-28

3. Deciphering Regulatory T-Cell Dynamics in Cancer Immunotherapy: Mechanisms, Implications, and Therapeutic Innovations;ACS Pharmacology & Translational Science;2024-07-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP